Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US

More Jobs >>

Events

Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Just Released: New Trends in Preventive and Therapeutic Vaccine
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia

More Events >>

GenVec News

Most Popular GenVec Story

Scripps wins $30M for HIV research center

October 2, 2008 — 7:23am ET | By John Carroll

Scripps Research Institute has won a $30 million grant from the International AIDS Vaccine Initiative to create a new research center that will hunt for a new vaccine to guard against HIV. The IAVI Read more...

GenVec Press Releases

GenVec Expands Collaboration With Merial
GenVec Inc. (GNVC) Achieves First Milestone in Collaboration, Eligible to Receive up to $213.6 Million on Sales
GenVec Announces Engagement of Financial Advisor to Evaluate Strategic Alternatives
GenVec Discontinues Phase 3 Clinical Trial of TNFerade
GenVec Receives an Approximately $2.5 Million Grant to Support Novel Cell Line Development

Latest Headlines

Scripps wins $30M for HIV research center
October 2, 2008

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK